https://www.avient.com/sites/default/files/2021-06/maxxam-fr-battery-pack-case-study-one-pager.pdf
https://www.avient.com/sites/default/files/2020-07/avient-abac-france-200718.pdf
Les collaborateurs d’Avient sont tenus de déterminer si l’activité proposée implique un représentant officiel public et si elle est acceptable, et doivent consulter le service juridique en cas de questions ou de préoccupations.
Dans ce cas, contactez immédiatement le directeur de la conformité de l’entreprise (ethics.officer@avient.com) ou le directeur juridique (legal.officer@avient.com).
L’ignorance délibérée, qui consiste notamment à ne pas procéder à une enquête raisonnable en cas de circonstances suspectes, ne constitue pas un argument de défense.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the United Arab Emirates.pdf
Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date.
With respect to the state of Ohio, this waiver applies to Section 35 Article II of the Ohio Constitution and Ohio Revised Code Sec. 4123.74. .
Buyer shall be exclusively responsible for (i) ensuring compliance with all Laws and Standards associated with its intended use of Product; and (ii) obtaining all necessary approvals, permits or clearances for such use.
https://www.avient.com/sites/default/files/2021-12/avient-sarl-hungary-branch-register-extract-2021-12-07.pdf
II.
Data not dependent on company form II.
https://www.avient.com/sites/default/files/2020-03/2020proxy.pdf
a) Section 5 Section 9 (b) (c) (d) Section 8 (e) (i) Person Outstanding Company Voting Securities (ii) Incumbent Board (iii) Business Combination (iv) (f) (g) Section 12 (h) (i) Section 13 (j) Section 10 Section 10 (k) (l) (m) (n) (o) Section 5 Section 9 (p) (q) (r) (s) (t) (u) Section 4 Section 9 (v) (w) Section 8 (x) Section 8 (y) Section 8 (z) (aa) (bb) Section 6 Section 9 (cc) Section 7 Section 9 (dd) Section 7 Section 9 (ee) (ff) (gg) Section 5 Section 9 (hh) 3.
Shares Available Under this Plan (a) (i) Section 12 Section 3(b) ( ) Section 9 Section 10 2017 Plan (ii) Section 3(b)( ) Section 3(a)(i) ( )( ) (b) (i) Section 22 Section 3(a)(i) ( )( ) (ii) (iii) Section 3(a)(i) ( )( ) Section 3(a)(i) ( )( ) Section 3(a)(i)( )( ) Section 3(a)(i)( )( ) (iv) Section 3(a)(i)( )( ) (c) Section 3 Section 12 (d) Section 3 (e) Section 3(e)( ) Section 3(a)(i) Section 12( )( ) Section 3(e)( ) Section 17(c)( ) 4.
Appreciation Rights (a) (b) (i) (ii) (iii) (iv) (v) (c) Section 22 (d) (e) (i) Section 22 (ii) (iii) 6.
https://www.avient.com/products/polymer-additives/healthcare-additives/mevopur-healthcare-functional-additives
Documented change control beyond CAS number
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the Kingdom of Saudi Arabia.pdf
Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date.
With respect to the state of Ohio, this waiver applies to Section 35 Article II of the Ohio Constitution and Ohio Revised Code Sec. 4123.74. .
Buyer shall be exclusively responsible for (i) ensuring compliance with all Laws and Standards associated with its intended use of Product; and (ii) obtaining all necessary approvals, permits or clearances for such use.
https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Titanium Dioxide.pdf
PHYSICAL/CHEMICAL PROPERTIES DOCUMENT NUMBER_ SSS-002 CATEGORY DETAIL EC Number 236-675-5 CAS Number 13463-67-7 Name Subclass 1 Titanium Dioxide (TiO2) Structural Formula O======Ti====== O PROPERTY DETAIL Physical State Solid Form Crystalline Color White Odor Odorless Melting Point 1560–1843°C Boiling Point 3,000°C Bulk Density 3.9 g/mL at 25°C Water Solubility Immiscible DOCUMENT NUMBER_ SSS-002 HEALTH EFFECTS HUMAN HEALTH SAFETY ASSESSMENT Consumer Based on available data, TiO2 is not a hazardous substance.
https://www.avient.com/sites/default/files/2022-12/Mevopur Colors for Ophthalmic Closures Application Bulletin_A4.pdf
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Standard concentrates in a PE carrier and on request in PP • Pre-colored formulations can be supplied in specific resins selected for the application REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN DRUG TYPE COLOR DESCRIPTION PANTONE REFERENCE AVIENT PRODUCT CODE PE BASED Adrenergic agonist combinations Light Green 373 C PE6M176349 Adrenergic agonists Purple 2583 C PE4M176057 Anti-infectives Tan 467 C PE8M176130 Anti-inflammatory, nonsteroidal Grey Cool Grey 4 C PE7M176184 Anti-inflammatory, steroids Pink 197 C PE3M176237 Anti-inflammatory, immunomodulators Olive Green 5763 C On request Beta-blockers Yellow Yellow C PE1M176160 Beta-blocker combinations Dark Blue 281 C PE5M176272 Carbonic anhydrase inhibitors Orange 1585 C PE2M176089 Cytotoxic Black 6 C PL9M176008 Miotics Dark Green 348 C PE6M176267 Mydriatics and cycloplegics Red 1797 C PE3M176236 Prostaglandin analogues Turquoise 326 C PE5M176273 Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Functional Additives Medical Devices Application Bulletin.pdf
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number reducing risk of change • Non-phthalate and formulated without animal- derived substances • Available for use in a wide range of polymers including polyolefins, styrenics, polycarbonate and alloys, polyester, POM • Functionality can be combined with colorants into convenient combination concentrates and ready-to-use formulations REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request FUNCTIONALITY TARGET APPLICATIONS DRUG DELIVERY DEVICES SYRINGES & NEEDLES DIAGNOSTICS CATHETERS Clarifying PP Sorbitol-free for transparent applications with reduced migration and improved thermal stability Lubricant— permanent/ non-migrating Fast acting reduction in friction for wide variety of polymers such as PP, ABS, POM, PC Protection from UV in transparent applications for PP, PE, PETG, COP UV blocking in 290-450nm with no impact on clarity; can be combined with colors (e.g., amber) Antistatic ready-to- use solution for PP, ABS, PC/ABS Permanent/non-migrating; fast decay time independent of % relative humidity Gamma/e-beam sterilization protection of the polymer Preserving the properties of PP and COC/COP; reduction in yellowing using Color Compensation Technology (CCT) Reduced material consumption/cycle time—nucleation Fast acting new generation nucleant for PE and PP; improved thermal and mechanical properties allows wall thinning; reduction of tolerance/dimensional problems between different colors Laser marking replacing ink printing/labels Solvent-free, high-speed identification for Nd/YAG laser for PE,PP, ABS, PC, POM Antioxidants for PE, PP, TPE Thermal protection during converting/downstream sterilization Brand protection/ anticounterfeit Covert and non-covert systems Healthcare use limitations apply—see below.